PRECISION OPTICS CORPORATION, INC.
Close on Oct 19, 2026
- Market cap
- $46.54M
- P/E (TTM)
- –
- Dividend yield
- –
About Precision Optics
Electromedical & Electrotherapeutic Apparatus, SIC 3845
Precision Optics Corporation, Inc. designs, develops, and manufactures specialized optical instruments, micro-optics, and digital imaging systems. The company primarily serves customers in the medical device, defense, and aerospace industries, including original equipment manufacturers that outsource complex assemblies. Its operational areas encompass systems manufacturing, engineering and product development, micro-optics laboratory services, and Ross Optical components. Key product offerings include traditional and digital CMOS endoscopes for reusable or single-use minimally invasive surgery, Microprecision lenses, micro medical cameras, optical illumination systems, and satellite communication components.
The company is headquartered in Littleton, Massachusetts, where it maintains principal executive offices. Precision Optics also conducts operations through its Ross Optical division based in El Paso, Texas, and electrical engineering operations originating from Windham, Maine. Optical components and specialized materials are sourced through a network of domestic and international suppliers. During the fiscal year ended June 30, 2026, the company served 266 customers, with two commercial clients generating the majority of its revenues.
Summary of the business section of Precision Optics's latest annual report, written by StockData.
Company profile
Company
- Legal name
- PRECISION OPTICS CORPORATION, INC.
- Founded
- 1982
- Headquarters
- Littleton, MA
- Address
- 550 King Street,, Bldg. A, Ste. 100 01460
- Phone
- (978) 630-1800
- Website
- poci.com
- Employees
- 108, Jun 30, 2026
- Industry
- Electromedical & Electrotherapeutic Apparatus
- Incorporated in
- Massachusetts
- Fiscal year ends
- June 30
- Auditor
- Stowe & Degon LLC, Westborough, Massachusetts
Stock & identifiers
- Ticker
- POCI
- Exchange
- Nasdaq
- Shares outstanding
- 11M, Sep 20, 2026
- Public float
- $25.60M, Dec 31, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- Stock splits
- 1-for-3 reverse, Feb 14, 2023; 1-for-3 reverse, Nov 2, 2022; 1-for-25 reverse, Dec 11, 2008; 1-for-6 reverse, Jan 29, 2003
- SEC CIK
- 867840
- CUSIP
- 740294400
- ISIN
- US7402944000
- EIN
- 04-2795294
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Joseph Norman Forkey | Chief Executive Officer, Director | 150,701 |
| Wayne M. Coll | Chief Financial Officer | 44,806 |
| Joseph Traut | Chief Operating Officer | 48,408 |
| Peter Richard Thier | Senior VP - Sales & Marketing | – |
| Mahesh Lawande | Chief Operating Officer | 1,726 |
| Andrew J. Miclot | Director | 13,628 |
| Peter H. Woodward | Director | 357,171 |
| Joseph P. Pellegrino JR | Director | – |
| Buell Duncan | Director | – |
| Peter V. Anania | Director | 147,548 |
| Richard B. Miles | Director | 6,037 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 Dr. Joseph Forkey | $1.11M | $1.03M | $288.57K | $92 | – |
| FY2024 Dr. Joseph Forkey | $251.03K | $251.03K | $284.62K | $109 | – |
| FY2023 Dr. Joseph Forkey | $240.39K | $240.39K | $209.53K | $116 | – |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“As of June 30, 2026, we had 108 employees, all”
Corporate history
Events identified from SEC filings